Avadel Pharma Earnings miss, Revenue Inline In Q2

  • Investing.com
Avadel Pharma Earnings miss, Revenue Inline In Q2

Investing.com - Avadel Pharma reported second quarter earnings that missed analysts' expectations on Monday and revenue that was inline with forecasts.

The firm reported earnings per share of $-0.33 on revenue of $0.00. Analysts polled by Investing.com forecast EPS of $-0.3125 on revenue of $0.00. .

Avadel Pharma shares lost 2.66% to trade at $7.690 in intra-day trade following the report.

For the year, Avadel Pharma shares are up 15.12%, broadly in line with the Nasdaq which is up 15.36% year to date.

Avadel Pharma follows other major Healthcare sector earnings this month


On Wednesday, July 21, 2021, J&J reported second quarter EPS of $2.48 on revenue of $23.31B, compared to forecasts of EPS of $2.29 on revenue of $22.49B.

Eli Lilly earnings missed analyst's expectations on Tuesday, August 3, 2021, with second quarter EPS of $1.87 on revenue of $6.74B. Investing.com analysts expected EPS of $1.89 on revenue of $6.6B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100